Interrogation of the tumor microenvironment of tumor specimens procured pre- and post-combination therapy revealed a higher intra-tumoral infiltration of CD8+ T cells (Figure 3C,D) and a higher expression of PD-L1 via immunohistochemistry (Figure 3E,F). This evidence concerns the gene CD8A and neoplasm.